GLP-1 receptor agonists slow gastric motility, which means food moves through your digestive tract more slowly
Preclinical and early clinical research into retatrutide has centered on its effects on body weight reduction, hepatic fat accumulation, insulin sensitivity, and appetite signaling
Glucagon receptor activation increases your body's resting metabolic rate (you burn more calories at rest) and promotes lipolysis (the breakdown of stored fat into energy)
Take out the pen and use a gauze pad or cotton to clean any blood or medication you see on the skin
However, around the time that bariatric surgerys positive effects on diabetes and cardiovascular outcomes were emerging from observational studies, researchers were taking note of the weight-loss and cardiovascular effects of the GLP-1 receptor agonist medications (GLP-1 RAs) used to treat type 2 diabetes
The next-generation GLP-1 drugs: retatrutide, CagriSema, and survodutide, work on more than one hormone